ETON: etonpharma.com Expected earnings per share growth for next year

Public company logo of Eton Pharmaceuticals (ETON)

A minimal environmental footprint and the digitalization of processes support the stability of Eton Pharmaceuticals (ETON), which confirms the earnings per share (EPS) forecast for the coming year. The value of 44.50 corresponds to the current metric of this indicator. Revenues are based on the sale of patented treatments for rare pathologies, while operational flexibility is ensured by the full outsourcing of manufacturing and clinical trials to external partners.

Eton Pharmaceuticals Inc (ETON): Net earnings per share change forecast for next year from 07/04/2022 to 11/17/2026

Analytical breakdowns and data insights for company Eton Pharmaceuticals Inc (ETON)

- share price and consensus valuation forecast:
Fundamental company valuation:ETON, etonpharma.com
Finished products of Eton Pharmaceuticals, Inc.

This indicator measures the expected growth rate of earnings per share, allowing for the identification of business value consolidation phases. For Eton Pharmaceuticals (ETON), which minimizes environmental costs through digitalization, this parameter reflects the efficiency of its operating model. Analyzing the forward EPS trend helps identify the risk of overpaying for the asset. A positive trend confirms growth potential without excessive capital expenditures.

Analysis of competing companies

VRTX (Vertex) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ALNY (Alnylam)|Expected earnings per share growth for next year INSM (Insmed)|UTHR (United Therapeutics Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year BioMarin BMRN|BBIO (BridgeBio Pharma Inc) - Net earnings per share change forecast for next year|BGM Group Ltd - Earnings growth forecast for next year|Expected earnings per share trend next year COGT (Cogent Biosciences)|XERS: Earnings growth forecast for next year|Keros Therapeutics Inc (KROS) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Arcturus Pharma|KMDA: Expected earnings per share trend next year|Net earnings per share growth forecast for next year fulcrumtx.com (FULC)|Expected earnings per share growth for next year Abeona Therapeutics Inc. ABEO|Earnings growth forecast for next year MREO (Mereo BioPharma Group)|PLX (Protalix BioTherapeutics Inc.) - Net earnings per share change forecast for next year|PLRX - Net earnings per share growth forecast for next year|APLT - Earnings growth forecast for next year|RNTX: Earnings growth forecast for next year|Expected net earnings per share growth next year Gelteq Limited Inc (GELS)|Expected earnings per share growth for next year AYTU|Expected net earnings per share growth next year chemomab.com CMMB|Expected earnings per share growth for next year SRXH (SRx Health Solutions Inc)|PLRZ - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Aeterna Zentaris AEZS|Cyclo Therapeutics, Inc. (CYTH) - Expected net earnings per share growth next year|INZY - Net earnings per share growth forecast for next year|Expected earnings per share trend next year RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Net earnings per share growth forecast for next year